Shengdar Tsai

Shengdar Tsai, PhD is an Associate Member in the Department of Hematology at St. Jude Children’s Research Hospital. He is the PI on two SCGE Phase 2 projects, titled “Optimization and qualification of biochemical CHANGE-seq unbiased genome-wide activity and gRNA sequencing methods for therapeutic genome editing INDs” and “Optimization and qualification of cellular unbiased GUIDE-seq-2 genome-wide activity method for genome editing INDs“.

In this interview, Dr. Tsai discusses how genome editing technologies have evolved since he started research and his hopes and predictions for how it will continue to grow over the next 10 years.

SCGE Phase 2 Publications Featuring Dr. Tsai